Original Research
Accepted on 13 Feb 2025
Gut Microbiota-Derived Metabolite Phenylacetylglutamine Inhibits the Progression of Prostate Cancer by Suppressing the Wnt/β-Catenin Signaling Pathway
in Pharmacology of Anti-Cancer Drugs
Original Research
Accepted on 13 Feb 2025
in Pharmacology of Anti-Cancer Drugs
Opinion
Accepted on 13 Feb 2025
in Blue Food Provisions
Review
Accepted on 13 Feb 2025
in Gastrointestinal Cancers: Gastric and Esophageal Cancers
Review
Accepted on 13 Feb 2025
in Signaling
Original Research
Accepted on 13 Feb 2025
in Reproduction
Original Research
Accepted on 13 Feb 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 13 Feb 2025
in Sleep and Circadian Rhythms
Original Research
Accepted on 13 Feb 2025
in Dermatology
Case Report
Accepted on 13 Feb 2025
in Neonatology
Original Research
Accepted on 13 Feb 2025
in Psychology of Aging
Original Research
Accepted on 13 Feb 2025
in Anesthesiology and Animal Pain Management
Editorial
Accepted on 13 Feb 2025
in Plant Conservation
Original Research
Accepted on 13 Feb 2025
in Auditory Cognitive Neuroscience
Original Research
Accepted on 13 Feb 2025
in Experimental Pharmacology and Drug Discovery
Systematic Review
Accepted on 13 Feb 2025
in Patient Safety
Correction
Accepted on 13 Feb 2025
in Cardiovascular Imaging